6595 Logo20300 2

Global Information, Inc. (JASDAQ 4171) has launched the new market research report “Rheumatoid Arthritis (RA) Therapy Area” on its premium market research portal, www.GIIResearch.com.

Request Free Sample: https://www.giiresearch.com/form/request/1058129

The latest report provides insights into the Rheumatoid Arthritis (RA) online landscape, from the perspective of multiple stakeholders, and offers an evaluation of the extensive competitive landscape in this space. It identifies and provides a detailed overview of present and developing patient needs, hot topics of conversation amongst physicians, and prominent digital opinion leaders. Additionally, the report will help assess how pharma companies are utilizing social media to engage in RA discussions, and understand ways in which to best connect with and support key customers. The report covers:

The Patient Voice

  • Patient Audiences in RA
  • Key Topics of Patient Conversation
  • Disease Experiences:
    • Diagnosis
    • Unmet Needs in Young Adult / Pregnant Women
    • Mental Health Impact
    • COVID-19 and RA
  • Treatment Experiences:
    • Brand Discussion
    • Treatment Switching
    • Safety Discussions
    • JAKiSafety Discussion and Key Questions Asked
    • Mode of Administration
    • Remission Discussion
  • Summary and Opportunities from the Patient Conversation

Clinical Conversations

  • Physician Online Audiences
  • Key Topics of Physician Conversation
  • Physician Views on JAKiSafety
  • Key Conference SoV
  • EULAR 2021 Discussions
  • ACR 2021 Discussions
  • Top Digital Opinion Leaders in RA
  • Summary and Opportunities from the Physician Conversation

Competitive Intelligence

  • Summary of Key Company Online Performance
  • Key Company Social Media Presence
  • Company Social Media Activity Overview:
    • UCB
    • Galapagos
    • BMS
    • Amgen
    • Pfizer
    • Sanofi
    • AbbVie
    • Genentech
    • Janssen
    • Eli Lilly
  • Summary and Opportunities from the Pharma Conversation

Request Free Sample: https://www.giiresearch.com/report/cel1058129-rheumatoid-arthritis-ra-therapy-area-report.html

Tags: PF-06835375, Nivolumab, JNJ-67484703, Janssen, Clinical Conversations, Patient Voice, Johnson & Johnson, Rheumatoid Arthritis, Ra, Pfizer

See Campaign: https://www.giiresearch.com/report/cel1058129-rheumatoid-arthritis-ra-therapy-area-report.html

Contact Information:

Global Information, Inc. (JASDAQ 4171) Toll Free (US): +1-866-353-3335 Outside US: +1-860-674-8796 Europe (Belgium): +32-2-535-7543 Email: marketing@giiresearch.com

Reportedtimes, PR-Wirein, Financial Content, IPS, Menafn, iCN Internal Distribution, Extended Distribution, Research Newswire, English